Summary
Updated Aug 31, 2026
Pankaj Mohan is Chairman, President and CEO, Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). 1 SEC Form 4 filing on record, dated 5 December 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Pankaj Mohan has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Pankaj Mohan go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Pankaj Mohan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Third Rock Ventures V, L.P. - $34.39M of RAPP open-market activity in the last 12 months
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Michael B. Petras Jr. - $33.51M of SHC open-market activity in the last 12 months
- Reuven Yeganeh - $33.32M of PHGE open-market activity in the last 12 months
- Adage Capital Management, L.P. - $33.20M of PRAX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pankaj Mohan?
Pankaj Mohan is a corporate insider, tracked as Chairman, President and CEO, Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pankaj Mohan last file a Form 4?
The only primary Form 4 on record is dated 5 December 2024.
Where can I see all of Pankaj Mohan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pankaj Mohan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial